Company intelligence / Profile preview

Hera Biomedical

Lexington, Kentucky, United Statesherabiopharm-usa.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Developing a non-surgical diagnostic test for endometriosis that uses molecular analysis of tissue collected via a simple in-office procedure

Therapeutic areas
Women's Health
Modalities
Molecular diagnosticsGene editing technology
Industry
Molecular Diagnostics
02

Drug pipeline

1 asset

IMGN853

Commercial
Indications
Ovarian cancer, Peritoneal cancer, Fallopian tube cancer, Endometrial cancer, Non-small cell lung cancer

Beyond the preview

Go deeper on Hera Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hera Biomedical.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call